Biopharma industry lobbies for tax breaks related to US-based manufacturing kdunleavy Tue, 03/21/2023 – 11:14 More: Biopharma industry lobbies for tax breaks related to US-based manufacturing Source: fierce
read moreGilead’s Yescarta puts pressure on BMS’ Breyanzi with overall survival win in large B-cell lymphoma fkansteiner Tue, 03/21/2023 – 11:14 More: Gilead's Yescarta puts pressure on BMS' Breyanzi with overall survival win in large B-cell lymphoma Source: fierce
read moreAs approvals roll in, Takeda details pricing strategy for dengue vaccine launch zbecker Tue, 03/21/2023 – 10:40 More: As approvals roll in, Takeda details pricing strategy for dengue vaccine launch Source: fierce
read moreBaxter attracts Thermo Fisher, Celltrion as potential buyers for biopharma contracting business: Reuters aliu Tue, 03/21/2023 – 10:12 More: Baxter attracts Thermo Fisher, Celltrion as potential buyers for biopharma contracting business: Reuters Source: fierce
read moreDespite CMS snub, Eisai is ‘not so nervous’ about Leqembi’s long-term coverage prospects: US CEO fkansteiner Tue, 03/21/2023 – 09:41 More: Despite CMS snub, Eisai is 'not so nervous' about Leqembi's long-term coverage prospects: US CEO Source: fierce
read moreCompany raises €12m in financing with a view to entering to the European market More: Vitestro raises vital funding for autonomous blood drawing device Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals